Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Haojie Rao"'
Autor:
Pengfei Xu, Yingjie Zhang, Junyan Guo, Huihui Li, Sandra Konrath, Peng Zhou, Liming Cai, Haojie Rao, Hong Chen, Jian Lin, Zhao Cui, Bingyang Ji, Jianwei Wang, Nailin Li, De-Pei Liu, Thomas Renné, Miao Wang
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Factor XII (FXII) is the zymogen of the plasma protease FXIIa that activates the intrinsic coagulation pathway and the kallikrein kinin-system. The role of FXII in inflammation has been obscure. Here, we report a single-domain antibody (nano
Externí odkaz:
https://doaj.org/article/af1ffc261c974bac96acdb6aa83394f7
Autor:
Yuze Zhang, Huihui Li, Yonghu Huang, Hong Chen, Haojie Rao, Guoli Yang, Qing Wan, Zekun Peng, John Bertin, Brad Geddes, Michael Reilly, Jean-Luc Tran, Miao Wang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Objective: Atherosclerosis is an arterial occlusive disease with hypercholesterolemia and hypertension as common risk factors. Advanced-stage stenotic plaque, which features inflammation and necrotic core formation, is the major reason for clinical i
Externí odkaz:
https://doaj.org/article/bed4fc5a2c524cefbc8309bacb3104fc
Autor:
Yuze Zhang, Julia Steinmetz‐Späh, Helena Idborg, Liyuan Zhu, Huihui Li, Haojie Rao, Zengrong Chen, Ziyi Guo, Lejia Hu, Chuansheng Xu, Hong Chen, Marina Korotkova, Per‐Johan Jakobsson, Miao Wang
Publikováno v:
British Journal of Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c28c1dfbfe723fbdb9f84f2cb94b59fc
https://doi.org/10.1111/bph.16061
https://doi.org/10.1111/bph.16061
Autor:
Qing Wan, Chuansheng Xu, Liyuan Zhu, Yuze Zhang, Zekun Peng, Hong Chen, Haojie Rao, Erli Zhang, Hongyue Wang, Fei Chu, Xuan Ning, Xuejian Yang, Jinqing Yuan, Yongjian Wu, Yu Huang, Shengshou Hu, De-Pei Liu, Miao Wang
Publikováno v:
Circulation research. 131(5)
Background:Timely and complete restoration of blood flow is the most effective intervention for patients with acute myocardial infarction. However, the efficacy is limited by myocardial ischemia-reperfusion (MI/R) injury. PDE4 (phosphodiesterase-4) h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a5ba6ebe1051a3fb5438bb507d6c51
https://pubmed.ncbi.nlm.nih.gov/35899614
https://pubmed.ncbi.nlm.nih.gov/35899614
Autor:
Qing Wan, Hong Chen, John Bertin, Zekun Peng, Yonghu Huang, Brad J. Geddes, Yuze Zhang, Jean-Luc Tran, Michael Reilly, Guoli Yang, Miao Wang, Haojie Rao, Huihui Li
Publikováno v:
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Objective: Atherosclerosis is an arterial occlusive disease with hypercholesterolemia and hypertension as common risk factors. Advanced-stage stenotic plaque, which features inflammation and necrotic core formation, is the major reason for clinical i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1006e77a1d3e3bf0442714512ffb5516
https://pubmed.ncbi.nlm.nih.gov/34760938
https://pubmed.ncbi.nlm.nih.gov/34760938